Epigenetic machine learning: utilizing DNA methylation patterns to predict spastic cerebral palsy
- PMID: 29925314
- PMCID: PMC6011336
- DOI: 10.1186/s12859-018-2224-0
Epigenetic machine learning: utilizing DNA methylation patterns to predict spastic cerebral palsy
Abstract
Background: Spastic cerebral palsy (CP) is a leading cause of physical disability. Most people with spastic CP are born with it, but early diagnosis is challenging, and no current biomarker platform readily identifies affected individuals. The aim of this study was to evaluate epigenetic profiles as biomarkers for spastic CP. A novel analysis pipeline was employed to assess DNA methylation patterns between peripheral blood cells of adolescent subjects (14.9 ± 0.3 years old) with spastic CP and controls at single CpG site resolution.
Results: Significantly hypo- and hyper-methylated CpG sites associated with spastic CP were identified. Nonmetric multidimensional scaling fully discriminated the CP group from the controls. Machine learning based classification modeling indicated a high potential for a diagnostic model, and 252 sets of 40 or fewer CpG sites achieved near-perfect accuracy within our adolescent cohorts. A pilot test on significantly younger subjects (4.0 ± 1.5 years old) identified subjects with 73% accuracy.
Conclusions: Adolescent patients with spastic CP can be distinguished from a non-CP cohort based on DNA methylation patterns in peripheral blood cells. A clinical diagnostic test utilizing a panel of CpG sites may be possible using a simulated classification model. A pilot validation test on patients that were more than 10 years younger than the main adolescent cohorts indicated that distinguishing methylation patterns are present earlier in life. This study is the first to report an epigenetic assay capable of distinguishing a CP cohort.
Keywords: Cerebral palsy; Computational statistics; DNA methylation; Epigenetic biomarkers; Genomics.
Conflict of interest statement
Ethics approval and consent to participate
Twenty-two subjects with a diagnosis of spastic CP and 21 control subjects were enrolled in this IRB-approved study at the Nemours - Alfred I. duPont Hospital for Children after written informed parental consent and subject assent. Approval for the study and the assent and consent documents was provided by Nemours Institutional Review Board 1, which has full accreditation from the Association for the Accreditation of Human Research Protection Programs and operates under the Federal Wide Assurance identification number FWA00000293.
Competing interests
The technology and software platform used to assess DNA methylation patterns were developed by Adam Marsh in his capacity as a professor of Computational Biology and Bioinformatics at the University of Delaware. The intellectual property is licensed by Genome Profiling LLC from the University. Author Adam Marsh declares a financial interest in Genome Profiling LLC.
Authors Erin Crowgey, Karyn Robinson, Stephanie Yeager, and Robert Akins have no competing interests.
Figures




Similar articles
-
Deep Learning/Artificial Intelligence and Blood-Based DNA Epigenomic Prediction of Cerebral Palsy.Int J Mol Sci. 2019 Apr 27;20(9):2075. doi: 10.3390/ijms20092075. Int J Mol Sci. 2019. PMID: 31035542 Free PMC article.
-
DNA Methylation Analysis Reveals Distinct Patterns in Satellite Cell-Derived Myogenic Progenitor Cells of Subjects with Spastic Cerebral Palsy.J Pers Med. 2022 Nov 30;12(12):1978. doi: 10.3390/jpm12121978. J Pers Med. 2022. PMID: 36556199 Free PMC article.
-
Whole‑genome scale identification of methylation markers specific for cerebral palsy in monozygotic discordant twins.Mol Med Rep. 2017 Dec;16(6):9423-9430. doi: 10.3892/mmr.2017.7800. Epub 2017 Oct 17. Mol Med Rep. 2017. PMID: 29039597 Free PMC article.
-
Advances in cerebral palsy biomarkers.Adv Clin Chem. 2021;100:139-169. doi: 10.1016/bs.acc.2020.04.006. Epub 2020 May 23. Adv Clin Chem. 2021. PMID: 33453864 Review.
-
Integrative Multi-Omics Research in Cerebral Palsy: Current Progress and Future Prospects.Neurochem Res. 2023 May;48(5):1269-1279. doi: 10.1007/s11064-022-03839-y. Epub 2022 Dec 13. Neurochem Res. 2023. PMID: 36512293 Review.
Cited by
-
Detection of suspicious interactions of spiking covariates in methylation data.BMC Bioinformatics. 2020 Jan 30;21(1):36. doi: 10.1186/s12859-020-3364-6. BMC Bioinformatics. 2020. PMID: 32000657 Free PMC article.
-
Rapid COVID-19 Prognostic Blood Test for Disease Severity Using Epigenetic Immune System Biomarkers.Dela J Public Health. 2020 Jul 1;6(2):26-29. doi: 10.32481/djph.2020.07.08. eCollection 2020 Jul. Dela J Public Health. 2020. PMID: 34467104 Free PMC article.
-
Resistance to Neuromuscular Blockade by Rocuronium in Surgical Patients with Spastic Cerebral Palsy.J Pers Med. 2021 Aug 3;11(8):765. doi: 10.3390/jpm11080765. J Pers Med. 2021. PMID: 34442409 Free PMC article.
-
Temporally discordant chromatin accessibility and DNA demethylation define short and long-term enhancer regulation during cell fate specification.bioRxiv [Preprint]. 2024 Aug 27:2024.08.27.609789. doi: 10.1101/2024.08.27.609789. bioRxiv. 2024. Update in: Cell Rep. 2025 May 27;44(5):115680. doi: 10.1016/j.celrep.2025.115680. PMID: 39253426 Free PMC article. Updated. Preprint.
-
Machine learning and clinical epigenetics: a review of challenges for diagnosis and classification.Clin Epigenetics. 2020 Apr 3;12(1):51. doi: 10.1186/s13148-020-00842-4. Clin Epigenetics. 2020. PMID: 32245523 Free PMC article. Review.
References
-
- Christensen D, Van Naarden Braun K, Doernberg NS, Maenner MJ, Arneson CL, Durkin MS, Benedict RE, Kirby RS, Wingate MS, Fitzgerald R, et al. Prevalence of cerebral palsy, co-occurring autism spectrum disorders, and motor functioning - autism and developmental disabilities monitoring network, USA, 2008. Dev Med Child Neurol. 2014;56(1):59–65. doi: 10.1111/dmcn.12268. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous